LEAP THERAPEUTICS INC (LPTX)

US52187K2006 - Common Stock

2.63  -0.11 (-4.01%)

After market: 2.7 +0.07 (+2.66%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.001.50M1.50M
Operating Expenses
59.13M87.04M56.76M42.93M30.04M
Research and Development
45.58M73.23M44.97M32.16M20.42M
Selling, General, and Administrative Expenses
13.55M13.81M11.80M10.77M9.62M
Operating Income
-59.13M-87.04M-56.76M-41.43M-28.54M
Interest Income/Expense
4.19M4.03M260.00K-410.00K790.00K
Other Income/Expense
1.57M1.60M2.05M1.23M230.00K
Income Before Taxes
-53.38M-81.41M-54.45M-40.61M-27.52M
Income Tax
N/A0.00150.00K-20.00K0.00
Net Income
-53.38M-81.41M-54.60M-40.59M-37.59M
EBITDA
N/A-87.03M-56.74M-41.40M-28.51M
 
Per Share Data
EPS Diluted Total Ops
-2.39-3.98-4.82-4.73-6.34
Non GAAP EPS
-2.39-5.08-4.70-0.48-0.55
 
Statistics
Profit Margin
N/AN/AN/A-2706.00%-2506.00%
Operating Profit Margin
N/AN/AN/A-2762.00%-1902.67%

All data in USD

Charts